Company Performance Metrics
RemiVida operates a digital health platform that facilitates access to alcohol reduction treatment based on the Sinclair Method using prescription medications such as Naltrexone and Nalmefene. The company coordinates online clinical assessments, connects users with independent prescribers and regulated pharmacies, and supports responsible
management of alcohol intake. Under The Drink Less Method brand, it offers starter and repeat prescription packs alongside optional at-home liver and blood testing provided via partner laboratories. RemiVida also provides clinically guided services for women, including testosterone therapy with AndroFeme, DHEA hormone support, and thyroid therapy, all initiated following blood tests and medical review. Its services are aimed at adults seeking structured, prescription-based treatment and remote diagnostic testing for alcohol-related health and hormonal concerns. All offerings are delivered through an ecommerce platform with clinically supervised pathways and use of accredited diagnostic partners.
